Legacy Pharmaceutical Packaging recalls

Legacy Pharmaceutical Packaging has 12 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 3 Jan 2024. 5 are still ongoing. The most frequent reason is packaging defects.

Total recalls12since 2013

Last 12 months0reported

Class I00% of total

Ongoing5latest 3 Jan 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 10 83%Class III 2 17%

Why legacy pharmaceutical packaging is recalled

Product types

Brands

Fluoxetine18%
Sertraline Hydrochloride18%

By year

202418%
202018%
2019542%
201718%
2014217%
2013217%

Ongoing legacy pharmaceutical packaging recalls

5 active

Reported	Class	Recall	Company	Reason	Where
3 Jan 2024Drug	CLASS II	Sertraline Tablets, USP 100 mg recalled by Legacy PharmaceuticalSertraline Hydrochloride	Legacy Pharmaceutical Packaging	Manufacturing (CGMP) Deviations	AR, CA
8 May 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	AZ, TN
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 25 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 100 mg recalled	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states

All legacy pharmaceutical packaging recalls, newest first

12 total

Reported	Class	Recall	Company	Reason	Where
3 Jan 2024Drug	CLASS II	Sertraline Tablets, USP 100 mg recalled by Legacy PharmaceuticalSertraline Hydrochloride	Legacy Pharmaceutical Packaging	Manufacturing (CGMP) Deviations	AR, CA
7 Oct 2020Drug	CLASS III	Metformin Hydrochloride Tablets USP, 1000 mg recalled	Legacy Pharmaceutical Packaging	Packaging Defects	AR, GA
8 May 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	AZ, TN
10 Apr 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	AZ, IN, TN
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 25 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states
27 Mar 2019Drug	CLASS II	Losartan Potassium Tablets, USP, 100 mg recalled	Legacy Pharmaceutical Packaging	Nitrosamine Impurity	5 states
29 Mar 2017Drug	CLASS II	Atenolol Tablets, USP, 50 mg recalled by Legacy Pharmaceutical	Legacy Pharmaceutical Packaging	Packaging Defects	Nationwide
18 Jun 2014Drug	CLASS II	Pantoprazole Sodium, Delayed-release tablets, USP dose packages recalled	Legacy Pharmaceutical Packaging	Packaging Defects	IN
7 May 2014Drug	CLASS II	Fluoxetine Capsules, USP, 20 mg recalled by Legacy PharmaceuticalFluoxetine	Legacy Pharmaceutical Packaging	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.